Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
SC 13D/A

An amendment to a SC 13D filing

Other
10-Q/A

Amendment to a previously filed 10-Q

Quarterly Filings
10-Q/A

Amendment to a previously filed 10-Q

Quarterly Filings
10-Q/A

Amendment to a previously filed 10-Q

Quarterly Filings
SC 13D/A

An amendment to a SC 13D filing

Other
SC 13D/A

An amendment to a SC 13D filing

Other
8-K

Report of unscheduled material events or corporate event

Current Reports
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
NT 10-Q

Notification that form type 10-Q will be submitted late

Quarterly Filings